utilities

Archive | Dementia research

Rare genetic discoveries driving breakthroughs for everyone affected by Alzheimer’s

Ed Pinches

Dr Selina Wray, an Alzheimer’s Research UK-funded scientist from University College London, and researchers from the UK Dementia Research Institute (UK DRI) have shed new light on how genetic mutations cause familial Alzheimer’s disease. Through your support, you have helped to support Dr Wray throughout her career, allowing her to build her expertise, grow her […]

Read more

Does Down’s syndrome hold the key to cracking Alzheimer’s?

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

It can come as a surprise to know that having Down’s syndrome puts people at much higher risk of Alzheimer’s. In fact, the genetic rearrangement that causes Down’s syndrome is one of the greatest genetic risk factors for Alzheimer’s. Sadly, everyone with Down’s syndrome will have developed the characteristic plaques and tangles of Alzheimer’s in […]

A closer look at a cannabis-based treatment in Alzheimer’s disease.

Ed Pinches

Dementia is a condition that people often associate with memory problems, but it can also affect people in many other ways. Behavioural changes someone with dementia may experience can sometimes be just as challenging, both for the person living with dementia, as well as their carers or family members. Thanks to your support, we are […]

Read more

The global research landscape 2018: hopes and highlights

Dr David Reynolds

Our Chief Scientific Officer, Dr David Reynolds looks back at key milestones in dementia research in 2018. The past 12 months have seen many important developments across the dementia research landscape– a field that unites governments and industry with health services and research institutes in urgent action to tackle diseases that affect more than 50 […]

Read more

4 emerging non-drug approaches to tackle dementia

Robin Brisbourne

When we think about future treatments for dementia our minds may immediately think of new drugs. From vaccines to antibiotics, aspirin to statins, drugs have had a revolutionary impact on our health and wellbeing. Developing new medicines is a major focus for the research you’re helping us to fund at Alzheimer’s Research UK and research […]

Read more

Behind the headlines: Pfizer finds new ways to support dementia research

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

Last week, pharmaceutical giant Pfizer announced it was backing new avenues of funding for neurodegeneration research – the area that includes research into Alzheimer’s and other diseases that cause dementia. This news comes just five months after Pfizer announced it would scale back its investment in dementia research, choosing to fund external projects rather than […]

Why I’ve been sharing my health data for over 70 years

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

We’re living in an era of big data that is influencing all aspects of our lives, but maybe our health most of all. From paper records kept in drawers at GP surgeries to creating networks of digital information that can be shared between GPs and hospitals, we are benefiting more than ever before from our […]

The Power of Big Data

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

It’s the hot topic, the subject dominating much of this month’s news. Data. Your data. How it is used, how it is stored, who gets to access it, and for what purpose. Earlier this month data was again the subject of conversation, this time among dementia researchers and experts in data science. They gathered in […]

Drug Discovery Alliance: An update on progress

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

This March saw 650 top dementia researchers attend the Alzheimer’s Research UK Research Conference. Delegates travelled from across the country and beyond to London to present their findings and gain insight into the cutting-edge science paving the way for new dementia treatments. A highlight of the conference, in which so much was covered, was a […]